The isolation and characterization of CTC subsets related to breast cancer dormancy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Vishnoi, Monika ^a   Peddibhotla, Sirisha ^b   Yin, Wei ^a   Scamardo, Antonio T ^c   George, Goldy C ^c   Hong, David S ^c   Marchetti, Dario ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; EPCAM PROTEIN, HUMAN; EPITHELIAL CELL ADHESION MOLECULE; PTPRC PROTEIN, HUMAN; TUMOR MARKER; UROKINASE RECEPTOR;

BRAIN TUMOR; BREAST TUMOR; CELL ADHESION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MIDDLE AGED; MULTICELLULAR SPHEROID; PATHOLOGY; PROCEDURES; SECONDARY; SINGLE CELL ANALYSIS; TUMOR CELL CULTURE; TUMOR EMBOLISM;

ANTIGENS, CD45; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL ADHESION; EPITHELIAL CELL ADHESION MOLECULE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SINGLE-CELL ANALYSIS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84948808509     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17533     Document Type: Article

References (47)

1. Aguirre-Ghiso, J. A. Models, mechanisms and clinical evidence forcancer dormancy. Nat. Rev. Cancer. 7, 834-46 (2007).
2. Sosa, M. S., Bragado, P., Aguirre-Ghiso, J. A. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat. Rev. Cancer. 14, 611-22 (2014).
3. Alix-Panabieres, C., Pantel, K. The circulating tumor cells: liquid biopsy of cancer. Klin Lab. Diagn. 4, 60-4 (2014).
4. Alix-Panabieres, C., Pantel, K. Challenges in circulating tumour cell research. Nat Rev Cancer. 14, 623-31 (2014).
5. Wan, L., Pantel, K., Kang, Y. Tumor metastasis: moving new biological insights into the clinic. Nat. Med. 19, 1450-64 (2013).
6. Joosse, S. A., Gorges, T. M., Pantel, K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol. Med. 7, 1-11 (2014).
7. Powell, A. A. et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One. 7, e33788 (2012).
8. Deng, G. et al. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow. BMC Cancer. 14, 456-68 (2014).
9. Meng, S. et al. Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer. Res. 10, 8152-62 (2004).
10. Plaks, V., Koopman, C. D., Werb, Z. Cancer. Circulating tumor cells. Science. 341, 1186-8 (2013).
11. Medress, Z., Hayden Gephart, M. Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation. Cureus. 7, e246 (2015).
12. Niikura, N., Saji, S., Tokuda, Y., Iwata, H. Brain metastases in breast cancer. Jpn J Clin Oncol. 44, 1133-40 (2014).
13. Zhang, L. et al. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci. Transl. Med. 5, 180ra48, 1-10 (2013).
14. Aguirre Ghiso, J. A., Kovalski, K., Ossowski, L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147, 89-104 (1999).
15. Aguirre-Ghiso, J. A., Ossowski, L., Rosenbaum, S. K. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 64, 7336-45 (2004).
16. Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature. 459, 1005-9 (2009).
17. Horibata, S., Vo, T. V., Subramanian, V., Thompson, P. R., Coonrod, S. A. Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. J. Vis. Exp. 99, e52727 (2015).
18. Grant, B.D., Donaldson, J. G. Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell. Biol. 10, 597-608 (2009).
19. Peeters, D. J. et al. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. Br. J. Cancer. 108, 1358-67 (2013).
20. Vinci, M. et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 10, 29-49 (2012).
21. Benton, G., Arnaoutova, I., George, J., Kleinman, H. K., Koblinski, J. Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv. Drug. Deliv. Rev. 79-80, 3-18 (2014).
22. Benton, G., DeGray, G., Kleinman, H. K., George, J., Arnaoutova, I. In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening. PLoS One. 10, e0123312 (2015).
23. Lorger, M., Felding-Habermann, B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am. J. Pathol. 176, 2958-71 (2010).
24. Sieuwerts, A.M. et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst. 101, 61-6 (2009).
25. Deng, G. et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res. 10, R69 (2008).
26. Kim, M.Y. et al. Tumor self-seeding by circulating cancer cells. Cell. 139, 1315-26 (2009).
27. Franken, B. et al. Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer. Breast Cancer Res. 14, R133 (2012).
28. Toyoda, K. et al. Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model. Cell Mol Neurobiol. 33, 489-501 (2013).
29. Okuda, H. et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res. 73, 1434-44 (2013).
30. Pitroda, S. P. et al. DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy. Sci Transl Med. 6, 229ra42 (2014).
31. Chen, H., et al. CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells. Zhonghua Zhong Liu Za Zhi. 29, 484-8 (2007).
32. Stengel, K., Zheng Y. Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell Signal. 23, 1415-23 (2011).
33. Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110-22 (2014).
34. Di Vizio, D. et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am. J. Pathol. 181, 1573-84 (2012).
35. Fonsatti, E. et al. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin. Cancer. Res. 6, 2037-43 (2000).
36. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-7 (2006).
37. Armstrong, A.J. et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res. 9, 997-1007 (2011).
38. Weaver, V. M. et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205-16 (2002).
39. Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90-4 (2011).
40. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-92 (2012).
41. Driessens, G. Deciphering tumor growth by clonal analysis. Crit. Rev. Oncog 19, 317-25 (2014).
42. Schepers, A. G. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science. 337, 730-5 (2012).
43. Dupont Jensen, J. et al. PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer. Clin. Cancer. Res. 17, 667-77 (2011).
44. Balasubramanian, P. et al. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck. PLoS One 7, e42048 (2012).
45. Klein, C.A. et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 96, 4494-9 (1999).
46. Klein, C. A. et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360, 683-9 (2002).
47. Jurinke, C., van den Boom, D., Cantor, C. R., Koster, H. The use of MassARRAY technology for high throughput genotyping. Adv. Biochem. Eng. Biotechnol. 77, 57-74 (2002).